Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 403-700-8 | CAS number: 2687-94-7 NOP; SURFADONE LP-100 SURFACTANT
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Bioaccumulation: aquatic / sediment
Administrative data
Link to relevant study record(s)
Description of key information
Significant accumulation in organisms is not expected.
Key value for chemical safety assessment
Additional information
QSAR-disclaimer:
In Article 13 of Regulation (EC) No 1907/2006, it is laid down that information on intrinsic properties of substances may be generated by means other than tests, provided that the conditions set out in Annex XI (of the same Regulation) are met.
Furthermore, according to Article 25 of the same Regulation testing on vertebrate animals shall be undertaken only as a last resort.
According to Annex XI of Regulation (EC) No 1907/2006 (Q)SAR results can be used if (1) the scientific validity of the (Q)SAR model has been established, (2) the substance falls within the applicability domain of the (Q)SAR model, (3) the results are adequate for the purpose of classification and labeling and/or risk assessment and (4) adequate and reliable documentation of the applied method is provided.
For the assessment of NOP (CAS 2687 -94 -7), (Q)SAR results were used for aquatic bioaccumulation. The criteria listed in Annex XI of Regulation (EC) No 1907/2006 are considered to be adequately fulfilled and therefore the endpoint(s) sufficiently covered and suitable for risk assessment.
Therefore, and for reasons of animal welfare, further experimental studies on aquatic bioaccumulation are not provided.
Assessment:
NOP has a log Kow of 4.15 at pH 7; therefore, accumulation in organisms is possible.
QSAR calculations indicate that significant accumulation is not expected especially when mitigating factors like metabolism and water solubility are taken into consideration. The table below lists the applied models together with information on the applicability domain and calculation options. The Arnot-Gobas model shows the effect of biotransformation on the BCF. Without biotransformation the BCF is significantly higher than with biotransformation (1440 L/kg vs. 94.7 L/kg). NOP is not completely in the applicability domain of the BCF baseline model v03.10 (QASIS Catalogic v5.13.1). The substance is within the parametric and the mechanistic domain, but not completely within the structural domain. 71% of the fragments were correctly predicted in the training chemicals, but 29% of the fragments of the substance were not within the training set of the model. However, the results can still be considered sufficiently reliable to support the other QSAR data with regard to the influence of mitigating factors like metabolism, molecular size and water solubility. The BCF is reduced from 1250 L/kg to 5.4 L/kg mainly due to the effect of metabolism and molecular size.
The BCF baseline v03.10 model predicted 6 metabolites on the first level of metabolism. The log Kow of the metabolites is significantly lower than that of the parent substance (NOP: log Kow = 4.15, measured; metabolites: log Kow = -0.32 to 2.81). The BCF was also predicted for the metabolites taking mitigating factors (e.g. metabolism, water solubility, molecular size) into consideration. The BCF values of the predicted metabolites are in a range from 3.0 to 11.7 L/kg (log BCF = 0.48 to 1.07). It can be concluded that, NOP as well as its metabolites are not expected to exhibit a significant bioaccumulation potential.
Studies for toxicological endpoints conducted on rats support the QSAR findings. The data on several studies with substance application for 28 d, 90 d and 120 d reveal a slight increase of liver weight. The observed effect did not exacerbate with application time and occured at comparable doses in all studies. Thus no hints for a bioaccumulation of the substance in rats were observed.
It can be concluded that based on the results of the QSAR models and the toxicological data, significant accumulation in organisms is not expected. Therefore, and for reasons of animal welfare, no study on bioaccumulation in fish is proposed.
Applied QSAR models: BCF and applicability domain
Model |
BCF [L/kg] |
In AD |
BCF baseline model v3.10 (OASIS Catalogic v5.13.1): including mitigating factors |
5.4 |
No (The substance is in the parametric and the mechanistic domain, but not completely in the structural domain (correct: 71.4%). |
BCFBAF v3.01 (EPI Suite v4.11): Meylan et al (1997/1999) |
10.7 |
Yes |
US EPA T.E.S.T.v4.2.1: Bioaccumulation: Consensus method |
32.9 |
Yes |
BCFBAF v3.01 (EPI Suite v4.11): Arnot-Gobas, upper trophic level, incl. biotransformation |
94.7 |
Yes |
BCFBAF v3.01 (EPI Suite v4.11): Arnot-Gobas, upper trophic level, without biotransformation |
1440 |
Yes |
BCF baseline model v3.10 (OASIS Catalogic v5.13.1): without mitigating factors |
1250 |
No (The substance is in the parametric and the mechanistic domain, but not completely in the structural domain (correct: 71.4%). |
Predicted metabolites (Catalogic BCF baseline v3.10 model): log Kow and corrected log BCF
Metab No |
Level |
Trans |
Phase I reaction |
Quantity |
Log Kow |
Smiles |
log BCF |
1 (parent) |
0 |
0 |
- |
0.002 |
4.15 |
CCCCCCCCN1CCCC1=O |
0.73 |
2 |
1 |
310 |
Aliphatic C-oxidation |
0.459 |
1.79 |
CCCCCCCCN1C(O)CCC1=O |
0.57 |
3 |
1 |
310 |
Aliphatic C-oxidation |
0.459 |
1.79 |
CCCCCCCC(O)N1CCCC1=O |
0.55 |
4 |
1 |
415 |
N-dealkylation |
4.8E-08 |
-0.32 |
O=C1CCCN1 |
0.48 |
5 |
1 |
415 |
N-dealkylation |
4.8E-08 |
2.81 |
CCCCCCCCO |
1.07 |
6 |
1 |
415 |
N-dealkylation |
4.8E-08 |
2.26 |
CCCCCCCCNC(=O)CCCO |
0.74 |
7 |
1 |
506 |
Omega oxidation |
0.081 |
1.87 |
OCCCCCCCCN1CCCC1=O |
0.57 |
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
